Abecma
idecabtagene vicleucel · BCMA CAR-TTest article vs clinical lot
Pharmacology used experimental CAR T batches without lot numbers; clinical drug product lots used for insertion site and growth studies. Bridging: Per certificates of testing, nonclinical experiment batches met the clinical lot release specifications
“*Lot Nos. were not assigned for CAR T cells assessed in nonclinical studies #1-8; they were manufactured under Experiment Nos.”
Genetically modified?
Autologous CD3+ CAR-T, lentiviral vector
“Idecabtagene vicleucel (ide-cel, bb2121) consists of autologous CD3+ T cells that are transduced using a lentiviral vector to express a BCMA-directed chimeric antigen receptor (CAR).”